Glucans as Biological Response Modifiers

E-ISSN： 2212-3873|9|1|67-75

ISSN： 1871-5303

Source： Endocrine, Metabolic & Immune Disorders-Drug Targets (Formerly Current Drug Targets - Immune, Endocrine & Metabolic Disorders), Vol.9, Iss.1, 2009-03, pp. : 67-75

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Biological Response Modifiers in the Treatment of Malignant Brain Tumours: Role of Interferons and Retinoids

By Uhm J.H. Yung W.K.A.

CNS Drugs, Vol. 10, Iss. 1, 1998-07 ,pp. : 11-24

Adis International

Access to resources Recommend Favorite

Structural Development of Biological Response Modifiers Based on Retinoids and Thalidomide

Mini Reviews in Medicinal Chemistry, Vol. 2, Iss. 6, 2002-12 ,pp. : 543-551

Bentham Science Publishers

Access to resources Recommend Favorite

Immune Therapy for Infectious Diseases at the Dawn of the 21st Century: the Past, Present and Future Role of Antibody Therapy, Therapeutic Vaccination and Biological Response Modifiers

Current Pharmaceutical Design, Vol. 9, Iss. 12, 2003-05 ,pp. : 945-968

Bentham Science Publishers

Access to resources Recommend Favorite

The Role of Topical Immune Response Modifiers in Skin Cancer

By Woodmansee Courtney Pillow Jessica Skinner Robert B.

Drugs, Vol. 66, Iss. 13, 2006-01 ,pp. : 1657-1664

Adis International

Access to resources Recommend Favorite

(1→3)--D-Glucans from Aspergillus spp.: Structural Characterization and Biological Study on their Carboxymethylated Derivatives

Current Drug Targets, Vol. 16, Iss. 13, 2015-12 ,pp. : 1488-1494

Bentham Science Publishers

Access to resources Recommend Favorite